Patient-centric platform Carenity operates a large online patient community with over 500,000 active members across Europe and North America, presenting a ready-made access point for real-world evidence studies, patient recruitment, and post-market research opportunities for life sciences clients.

Global reach, diverse diseases With access to thousands of patients across 1,200+ diseases and collaborations in scientific publications, Carenity offers broad disease coverage and high-quality patient insights that can support clinical development, market access, and pharmacovigilance initiatives for pharma and device manufacturers.

Proven research capabilities Carenity provides direct-to-patient online research and established services like PatientLive, backed by a track record of 500+ publications, enabling rapid deployment of real-world evidence studies for epidemiology, patient preference research, and outcome measurements.

Strategic partnerships As part of the EvidentIQ Group since 2021, Carenity leverages a broader ecosystem for data access and analytics, presenting opportunities for joint offerings, data integration, and expanded commercial reach into global life sciences networks.

Growth with enterprise buyers Despite a lean team and revenue under one million, Carenity has exposure to enterprise clients through partnerships and acquisitions in the digital CRO space, suggesting potential up-sell of comprehensive patient-centric research platforms and enterprise data services to biopharma, med devices, and contract research organizations.